Publications by authors named "Olaf Randerath"

Claim this Profile
P
Prevalence and Medical Treatment of Arterial Hypertension and Hypercholesterolemia in Germany: a Nationwide questionnaire-based Survey in Medical Practices.
Christian Beger, Olaf Randerath, Astrid Mayerböck, Konrad Klein, Florian P Limbourg

High Blood Press Cardiovasc Prev· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of a single pill concept on clinical and pharmacoeconomic outcomes in cardiovascular diseases.
Burkhard Weisser, Sven Wassmann, Hans-Georg Predel, Roland E Schmieder, Anton Gillessen, Olaf Randerath

Eur Heart J Cardiovasc Pharmacother· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current practice of blood pressure measurement in Germany: a nationwide questionnaire-based survey in medical practices.
Christian Beger, Astrid Mayerböck, Konrad Klein, Theresa Karg, Kai M Schmidt-Ott, Olaf Randerath

Blood Press· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved Persistence to Medication, Decreased Cardiovascular Events and Reduced All-Cause Mortality in Hypertensive Patients With Use of Single-Pill Combinations: Results From the START-Study.
Roland E Schmieder, Sven Wassmann, Hans-Georg Predel, Burkhard Weisser, Jörg Blettenberg, Olaf Randerath

Hypertension· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of cardiovascular single pill combinations compared with identical multi-pill therapies on healthcare cost and utilization in Germany.
Thomas Wilke, Burkhard Weisser, Hans-Georg Predel, Roland E Schmieder, Sven Wassmann, Olaf Randerath

J Comp Eff Res· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Single Pill Combinations Compared to Identical Multi Pill Therapy on Outcomes in Hypertension, Dyslipidemia and Secondary Cardiovascular Prevention: The START-Study.
Thomas Wilke, Burkhard Weisser, Hans-Georg Predel, Roland Schmieder, Sven Wassmann, Olaf Randerath

Integr Blood Press Control· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of Candesartan, Amlodipine, and Atorvastatin in Combination: Interaction Study in Healthy Subjects.
Kristina Gundlach, Katharina Wolf, Isam Salem, Olaf Randerath, Dan Seiler

Clin Pharmacol Drug Dev· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single Pill Regimen Leads to Better Adherence and Clinical Outcome in Daily Practice in Patients Suffering from Hypertension and/or Dyslipidemia: Results of a Meta-Analysis.
Burkhard Weisser, Hans-Georg Predel, Anton Gillessen, Claudia Hacke, Johannes Vor dem Esche, Olaf Randerath

High Blood Press Cardiovasc Prev· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of arterial hypertension: Transfer from clinical guidelines into daily practice - Results of a survey in German practitioners offices.
Hans-Georg Predel, Fabian Graas, Georg Rudinger, Olaf Randerath

J Educ Health Promot· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Requirements for Parkinson's disease pharmacotherapy from the patients' perspective: a questionnaire-based survey.
Ullrich Wüllner, Gerd Fuchs, Nicole Reketat, Olaf Randerath, Jan Kassubek

Curr Med Res Opin· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High doses of rotigotine transdermal patch: results of an open-label, dose-escalation trial in patients with advanced-stage, idiopathic Parkinson disease.
Ivan Rektor, Tomislav Babic, Bernard Boothmann, Jiri Polivka, Babak Boroojerdi, Olaf Randerath

Clin Neuropharmacol· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rotigotine transdermal patch enables rapid titration to effective doses in advanced-stage idiopathic Parkinson disease: subanalysis of a parallel group, open-label, dose-escalation study.
Tomislav Babic, Bernard Boothmann, Jiri Polivka, Ivan Rektor, Babak Boroojerdi, Olaf Randerath

Clin Neuropharmacol· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis